Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Envista Holdings Corp (NVST)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: NVST (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $21.42
1 Year Target Price $21.42
| 3 | Strong Buy |
| 0 | Buy |
| 10 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -15.15% | Avg. Invested days 35 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.46B USD | Price to earnings Ratio 65.06 | 1Y Target Price 21.42 |
Price to earnings Ratio 65.06 | 1Y Target Price 21.42 | ||
Volume (30-day avg) 14 | Beta 1.01 | 52 Weeks Range 14.22 - 23.00 | Updated Date 08/15/2025 |
52 Weeks Range 14.22 - 23.00 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.32 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-31 | When After Market | Estimate 0.23 | Actual 0.26 |
Profitability
Profit Margin 2.11% | Operating Margin (TTM) 7.45% |
Management Effectiveness
Return on Assets (TTM) 2.2% | Return on Equity (TTM) 1.76% |
Valuation
Trailing PE 65.06 | Forward PE 18.83 | Enterprise Value 3945503410 | Price to Sales(TTM) 1.36 |
Enterprise Value 3945503410 | Price to Sales(TTM) 1.36 | ||
Enterprise Value to Revenue 1.55 | Enterprise Value to EBITDA 13.01 | Shares Outstanding 166182000 | Shares Floating 165596760 |
Shares Outstanding 166182000 | Shares Floating 165596760 | ||
Percent Insiders 0.56 | Percent Institutions 118.28 |
Upturn AI SWOT
Envista Holdings Corp
Company Overview
History and Background
Envista Holdings Corp. was formed in 2019 when Danaher Corporation spun off its dental segment. It has quickly established itself as a leading player in the dental industry by combining its established brands and technologies.
Core Business Areas
- Specialty Products & Technologies: This segment includes orthodontics solutions (braces, aligners), implants, and associated products for dental specialists.
- Essential Dental Technologies: This segment focuses on core dental technologies, including restorative materials, endodontic solutions, and infection prevention products for general dentists.
Leadership and Structure
Amir Aghdaei is the current CEO. Envista operates with a decentralized structure, empowering its individual operating companies to focus on innovation and customer service.
Top Products and Market Share
Key Offerings
- Ormco: Ormco is a leading brand in orthodontics, offering a full line of braces and aligners. They compete with Align Technology (ALGN) and 3M (MMM) in the orthodontics market. While exact market share fluctuates, Ormco holds a significant portion of the traditional braces market. Revenue data specific to Ormco is not publicly broken out in Envista's financial reports.
- Nobel Biocare: Nobel Biocare is a well-known brand in dental implants, providing comprehensive solutions for implant dentistry. Competitors include Straumann and Dentsply Sirona (XRAY). Nobel Biocare maintains a strong position in the premium implant segment. Revenue data specific to Nobel Biocare is not publicly broken out in Envista's financial reports.
- Kerr: Kerr offers a broad range of dental restorative materials, consumables and equipment used in general dental practices. Competitors include Dentsply Sirona and 3M. Revenue data specific to Kerr is not publicly broken out in Envista's financial reports.
Market Dynamics
Industry Overview
The dental industry is characterized by growing demand driven by an aging population, increased awareness of oral health, and technological advancements. Digital dentistry and minimally invasive procedures are gaining traction.
Positioning
Envista is positioned as a leading provider of dental products and technologies, with a strong focus on innovation and customer service. Its diverse portfolio allows it to cater to a wide range of dental professionals and patients.
Total Addressable Market (TAM)
The global dental market is estimated at over $40 billion. Envista is well-positioned to capture a significant share of this market through its established brands and innovative products. The exact TAM portion attributed to the markets Envista participates within is not specifically disclosed.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Global presence
- Focus on innovation
- Decentralized operating model
- Strong relationships with dental professionals
Weaknesses
- Dependence on macroeconomic conditions
- Exposure to regulatory changes
- Integration risks from acquisitions
- Exposure to foreign exchange rate fluctuations
- Susceptibility to commodity price increases
Opportunities
- Expansion into emerging markets
- Development of new products and technologies
- Acquisitions of complementary businesses
- Growth in digital dentistry
- Increased adoption of minimally invasive procedures
Threats
- Intense competition
- Technological disruption
- Economic downturns
- Changes in reimbursement policies
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- XRAY
- ALGN
- DHR
- 3M
Competitive Landscape
Envista competes with larger, more diversified companies like Dentsply Sirona and Align Technology. Its competitive advantage lies in its specialized focus and strong brands. However, its smaller size can be a disadvantage in terms of resources.
Major Acquisitions
Carestream Dental's Intra-Oral Scanner Business
- Year: 2024
- Acquisition Price (USD millions): 600
- Strategic Rationale: Expanding its digital dentistry offerings and increasing its presence in the intraoral scanning market.
Growth Trajectory and Initiatives
Historical Growth: Envista has experienced steady growth since its spin-off, driven by organic growth and acquisitions.
Future Projections: Analyst estimates vary, but generally project continued growth in revenue and earnings, driven by innovation and market expansion.
Recent Initiatives: Recent initiatives include investments in digital dentistry, expansion into new markets, and acquisitions of complementary businesses.
Summary
Envista is a solid player in the dental industry with a strong brand portfolio and a focus on innovation. Its decentralized structure allows for flexibility and responsiveness to market changes. The company's lack of a dividend may deter some investors, and its smaller size relative to competitors presents certain challenges. The acquisition of Carestream Dental will strengthen the companies digital portfolio which will allow growth in the digital segment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Envista Holdings Corp. Investor Relations
- SEC Filings (10-K, 10-Q)
- Analyst Reports
- Market Research Reports
- Company Press Releases
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Investment decisions should be based on your own due diligence and consultation with a qualified financial advisor. Market share data is based on available information and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envista Holdings Corp
Exchange NYSE | Headquaters Brea, CA, United States | ||
IPO Launch date 2019-09-18 | CEO & Director Mr. Paul A. Keel | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 12300 | Website https://envistaco.com |
Full time employees 12300 | Website https://envistaco.com | ||
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.